Company: INMB
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001213900-25-033742
Chunk: 4

Company: Inmune Bio, Inc.
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 4
---
 no dissenters’ rights available to the Company’s stockholders with respect to any matter to be voted on at the Meeting. Q:What do I need to do now? A:We encourage you to read this entire proxy statement, and the documents we refer to in this proxy statement Then complete, sign, date and return, as promptly as possible, the enclosed proxy card in the accompanying reply envelope or grant your proxy electronically over the Internet or by telephone, so that your shares can be voted at the Meeting. If you hold your shares in “street name,” please refer to the voting instruction forms provided by your broker, bank or other nominee to vote your shares. Q:What quorum is required for the Meeting? A:A quorum will exist at the Meeting if the holders of record of 33.3 percent of the capital stock issued and outstanding and entitled to vote thereat, present in person or represented by proxy. Shares of the Company’s common stock that are voted to abstain are treated as shares that are represented at the Meeting for purposes of determining whether a quorum exists. Q:Who will tabulate the votes? A:The Company has designated a representative of Broadridge Financial Solutions as the Inspector of Election who will tabulate the votes. Q:What vote is required in order for the proposals to be approved? A:Provided a quorum is present, the following are the voting requirements for each proposal: •Proposal 1. To elect five (5) directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified. The five (5) nominees receiving a majority number of votes will be elected. 2 •Proposal 2. To ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the year ending December31, 2025. Approval of the ratification of our independent registered public accounting firm requires the affirmative vote of a majority of the shares present in person or by proxy. •Proposal 3. The Say on Pay Proposal must receive “For” votes from holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter. Abstentions will count towards the quorum requirement for the annual meeting but will not count as a vote for or against Proposal 3. •Proposal 4. You have four choices for voting on this proposal. You may indicate your preference, on an advisory basis, as to whether future advisory votes on named executive officer compensation should be conducted every ONE YEAR, TWO